Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2018 Aug 25;25(1):163–171. doi: 10.1016/j.bbmt.2018.08.021

Table 3.

Risk factors for LRTD without prior URTI (N=121)

Univariable analysis Multivariable analysis
OR 95% CI P Value OR 95% CI P Value
Age at PIV infection
 ≤ 20 0.25 0.1–1.3 0.09
 21–60 0.44 0.1–1.5 0.19
 > 60 1.00
Cell source
 PBSC 1.00 1.00
 BM or CB 0.39 0.2–0.8 0.012 0.47 0.1–1.7 0.25
%FEV1/FVC pre PIV infection
 ≥ 70 1.00
 < 70 2.25 0.9–5.6 0.08
%TLC pre PIV infection
 ≥ 80 1.00 1.00
 < 80 3.41 1.1–10.3 0.030 5.56 1.1–25.0 0.036
Days between transplantation and PIV infection
 ≤ 30 0.92 0.4–2.4 0.87
 31–100 0.42 0.2–1.0 0.047
 > 100 1.00
Inpatient at diagnosis
 No 1.00 1.00
 Yes 3.44 1.6–7.3 0.001 1.61 0.4–6.0 0.48
Diagnosis on weekday
 No 1.00
 Yes 0.51 0.2–1.5 0.21
Documented URTI symptom at diagnosis
 No 1.00 1.00
 Yes 0.19 0.1–0.4 <.001 0.17 0.0–0.7 0.017
LRTD symptom at diagnosis
 No 1.00
 Yes 3.37 1.1–10.3 0.033
PIV type
 PIV-1, 2, 4 1.00
 PIV-3 0.26 0.1–1.0 0.049
Co-pathogen
 No / Blood alone 1.00 1.00
 Upper respi ratory tract 0.38 0.0–3.5 0.40 0.41 0.0–40.1 0.24
 Lower respi ratory tract 14.60 4.1–52.0 <.001 43.70 6.0–321 0.006
Oxygen use at diagnosis
 No 1.00 1.00
 Yes 10.30 4.4–24.5 <.001 9.51 2.2–41.2 0.003
Steroid dose before diagnosis
 No 1.00
 < 1 mg/kg 1.80 0.7–4.7 0.23
 1–2 mg/kg 0.38 0.2–0.9 0.034
 > 2 mg/kg 1.96 0.3–11.3 0.45

All variables in Supplemental Table 1 were used for the univariate analysis. Only variables with p < 0.1 in any analysis except diagnosis on weekday are shown in this table. The most informative multivariable model is shown here and additional models with different combinations of risk factors did not yield other factors that remained after adjustment.

Abbreviations: PBSC, periperal blood stem cell; BM, bone marrow; CB, cord blood; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity